TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

DSPACE

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

DSPACE

ST13

US500000079367886

Classe

5, 10, 44

Pedido

79367886

Registro

7445274

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

34

Atualização mais recente

03/04/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

5, 10, 44

Data de depósito

23/09/2022

Data de registro

16/07/2024

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

16/07/2024

Última transação

03/04/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

99

Localização do titular

DE

Examinador

HOPKINS, SARAH COLLEEN

Unidade examinadora

N50

Localização atual

Historical data usage

Titulares e representantes

Titulares

DAIICHI SANKYO EUROPE GmbH

Representantes

Douglas R. Wolf Wolf, Greenfield & Sacks, P.C.

Classificação técnica

Classes Nice

Classe 5Classe 10Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Pharmaceuticals, medical and veterinary preparations for the treatment of cancer, cardiovascular diseases and disorders, respiratory diseases and disorders, neurological diseases and disorders, psychiatric diseases and disorders, gastrointestinal diseases and disorders, immunological diseases and disorders, metabolic diseases and disorders, endocrine diseases and disorders, kidney diseases and disorders, dermatological diseases and disorders, reproductive diseases and disorders, urological diseases and disorders, allergies, bone diseases and disorders, diseases and disorders of the musculo-skeletal and genitourinary systems, and viruses and infectious diseases; sanitary preparations for medical purposes; dietetic foods adapted for medical and veterinary purposes, food for babies; dietary supplements for human beings and animals; medical plasters, materials for dressings, namely, medical dressings; disinfectants; medicinal healthcare preparations, namely, biological preparations for the treatment of cancer, cardiovascular diseases and disorders, respiratory diseases and disorders, neurological diseases and disorders, psychiatric diseases and disorders, gastrointestinal diseases and disorders, immunological diseases and disorders, metabolic diseases and disorders, endocrine diseases and disorders, kidney diseases and disorders, dermatological diseases and disorders, reproductive diseases and disorders, urological diseases and disorders, allergies, bone diseases and disorders, diseases and disorders of the musculo-skeletal and genitourinary systems, and viruses and infectious diseases * ; the aforesaid goods solely aimed at those involved in a healthcare system, namely healthcare service recipients, namely patients, healthcare service providers, namely doctors, healthcare service financers/healthcare service payers, namely insurance providers, in the field of digital health *

Classe 10

Surgical apparatus and instruments; therapeutic and assistive devices adapted for persons with disabilities, namely, body rehabilitation apparatuses for medical purposes; testing apparatus for medical purposes, namely, blood testing apparatus; diagnostic apparatus, namely, apparatus for the detection, diagnosis, and treatment of cancer, cardiovascular diseases and disorders, respiratory diseases and disorders, neurological diseases and disorders, psychiatric diseases and disorders, gastrointestinal diseases and disorders, immunological diseases and disorders, metabolic diseases and disorders, endocrine diseases and disorders, kidney diseases and disorders, dermatological diseases and disorders, reproductive diseases and disorders, urological diseases and disorders, allergies, bone diseases and disorders, diseases and disorders of the musculo-skeletal and genitourinary systems, and viruses and infectious diseases for medical purposes; electronic apparatus for medical purposes, namely, electronic stimulation apparatus for nerves, skin, and muscles for physical therapy purposes; medical imaging apparatus; electronic medical instruments, namely, electronic medical appliances for performing surgery; medical diagnostic apparatus for medical purposes, namely, ultrasound and x-ray diagnostic apparatuses * ; the aforesaid goods solely aimed at those involved in a healthcare system, namely healthcare service recipients, namely patients, healthcare service providers, namely doctors, healthcare service financers/healthcare service payers, namely insurance providers, in the field of digital health *

Classe 44

Medical services; consulting services relating to health care, namely, consulting in the field of healthcare; health counselling; providing health assessment services in the nature of health assessment surveys; providing health information; health assessment services; information services relating to health care; human healthcare services; health clinic services; health resort services, namely, health care services for wellness of the mind, body and spirit; managed health care services; home health care services; provision of health information; medical health assessment services; medical and healthcare services; health advice and information services; health care consultancy services; rental of medical and health care equipment; health care services offered through a network of health care providers on a contract basis; preparation of reports relating to health care matters; providing health care information via a global computer network; medical information; medical counseling; medical consultations; medical examinations; medical care; medical diagnostic services; providing medical physical evaluation services; medical equipment rental; rental of equipment, namely, rental of medical equipment; advisory services relating to medical problems; telemedicine services; providing medical information in the healthcare sector; providing on-line information relating to the prevention of cardiovascular disease and strokes; medical screening services relating to cardiovascular disease; providing information relating to the treatment of cardiovascular and cerebrovascular diseases via the internet; personalised health care and medical care; providing information to patients in the field of administering medications and medical and health care services through the use of software being telemedicine services; provision of health care support services for patients, namely, drug reminders being interactive medical monitoring and alert service for reminding clients of medicinal dosage, allergic sensitivity, and prescription refills for treatment purposes, nutrition consulting; information relating to the use of medicines * ; the aforesaid services solely aimed at those involved in a healthcare system, namely healthcare service recipients, namely patients, healthcare service providers, namely doctors, healthcare service financers/healthcare service payers, namely insurance providers, in the field of digital health *

Publicações

Histórico de despachos e eventos da marca no USPTO.

34 publicações encontradas

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

17/01/2025

FICS

FINAL DISPOSITION NOTICE SENT TO IB

27/12/2024

FIMP

FINAL DISPOSITION PROCESSED

27/12/2024

NURC

NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED

26/11/2024

LIME

LIMITATION FROM THE IB EXAMINED AND ENTERED

05/11/2024

COC.

CORRECTION UNDER SECTION 7 - PROCESSED

04/11/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

04/11/2024

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

17/10/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

16/07/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

16/07/2024

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

07/07/2024

GPNX

NOTIFICATION PROCESSED BY IB

30/04/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

30/04/2024

PUBO

PUBLISHED FOR OPPOSITION

30/04/2024

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

10/04/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/04/2024

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

10/04/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

22/03/2024

XAEC

EXAMINER'S AMENDMENT ENTERED

22/03/2024

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

22/03/2024

GNEA

EXAMINERS AMENDMENT E-MAILED

22/03/2024

CNEA

EXAMINERS AMENDMENT -WRITTEN

22/03/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

20/02/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

20/02/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

20/02/2024

RFNT

REFUSAL PROCESSED BY IB

05/09/2023

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

17/08/2023

RFRR

REFUSAL PROCESSED BY MPU

17/08/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

18/07/2023

CNRT

NON-FINAL ACTION WRITTEN

17/07/2023

DOCK

ASSIGNED TO EXAMINER

08/07/2023

MAFR

APPLICATION FILING RECEIPT MAILED

25/04/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

21/04/2023

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

20/04/2023

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace DSPACE ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.